http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9725482-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af1b5d15457064e7ecc4d0727bf6da2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe882eed97fb4672fb673e42a3d298cd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 |
| filingDate | 2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eff03374c6da59da4583d9e57682714 |
| publicationDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-9725482-B2 |
| titleOfInvention | Pentacyclic triterpenoid compound with modified structure and preparation method and use thereof |
| abstract | The present invention relates to new pentacyclic triterpenes, their preparation method and use. The compounds of the present invention could effectively treat psoriasis and selectively inhibit in vitro differentiation of the T H 1 and T H 17 cells, thereby could be used to treat the T H 1- or T H 17-mediated autoimmune diseases. |
| priorityDate | 2013-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 306.